Browse diseases

…ive plasma samples were processed for WGS using the QIAseq xHYB HIV-1 kit (Qiagen) and sequenced on the MiSeq platform (Illumina). A …

… tissue (GALT).Materials and Methods Sixty-seven virosuppressed PWH were enrolled, 32 continued 3-DR and 35 switched to 2-DR. Perip…

…ntramuscular antiretroviral regimen approved for maintenance of HIV-1 virological suppression. Real-world data on durability and reas…

…s Switching to LA-CAB/RPV maintains virological suppression and HIV-DNA stability over 24 months. The significant reduction in plasma N…

…-cell nadir, higher current CD4+ T-cell counts, and lower total HIV-1 DNA levels and in multivariable analysis, CD4+ T-cell nadir was…

…Objectives Αn HIV-1 outbreak was identified among people who inject drugs (PWID) in…

…while at T7 a more marked reduction was observed. Subjects with virological failure showed higher CAD and CAR levels, although differences were not…

…r 2025. Eligible participants had documented viral suppression (HIV-1 RNA <50 copies/mL) for at least 6 months prior to switch. Demog…

…sociated with significant weight gain and potentially also with cardiometabolic disorders. In an effort to expand therapeutic options for people living w…

…between the centres. These findings highlight the resilience of HIV care systems in Italy and the importance of maintaining tireles…

…th confirmed optimal adherence. It highlights that breakthrough HIV infection can occur even after many years of successful PrEP us…

… Islatravir (ISL) has shown sustained activity against multiple HIV-1 subtypes and high potency even in the presence of several NRTI …